Peak cerebrospinal fluid platinum levels in a patient with ependymoma

Evaluation of two different methods of cisplatin administration

M. DeGregorio, B. Wilbur, O. King, J. Wallenberg, S. Prewitt, J. Phillips

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Peak CSF and serum platinum levels were examined in a patient with ependymoma after each of four consecutive cisplatin doses of 100 mg/m2 administered by either 30-minute or 3-hour infusion. Both infusion lengths produced similar peak CSF platinum levels within 2 hours after the completion. Ultrafiltrate serum platinum levels correlated with the CSF platinum levels, whereas total plasma platinum did not. No differences in clinical toxicity or response were seen between the two methods of administration. Based on these preliminary results, similar peak CSF platinum concentrations are achieved by 30-minute or 3-hour infusions, and ultrafiltrate serum platinum concentrations can be used to predict these levels.

Original languageEnglish (US)
Pages (from-to)1437-1438
Number of pages2
JournalCancer Treatment Reports
Volume70
Issue number12
StatePublished - 1986
Externally publishedYes

Fingerprint

Ependymoma
Platinum
Cisplatin
Cerebrospinal Fluid
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

DeGregorio, M., Wilbur, B., King, O., Wallenberg, J., Prewitt, S., & Phillips, J. (1986). Peak cerebrospinal fluid platinum levels in a patient with ependymoma: Evaluation of two different methods of cisplatin administration. Cancer Treatment Reports, 70(12), 1437-1438.

Peak cerebrospinal fluid platinum levels in a patient with ependymoma : Evaluation of two different methods of cisplatin administration. / DeGregorio, M.; Wilbur, B.; King, O.; Wallenberg, J.; Prewitt, S.; Phillips, J.

In: Cancer Treatment Reports, Vol. 70, No. 12, 1986, p. 1437-1438.

Research output: Contribution to journalArticle

DeGregorio, M, Wilbur, B, King, O, Wallenberg, J, Prewitt, S & Phillips, J 1986, 'Peak cerebrospinal fluid platinum levels in a patient with ependymoma: Evaluation of two different methods of cisplatin administration', Cancer Treatment Reports, vol. 70, no. 12, pp. 1437-1438.
DeGregorio, M. ; Wilbur, B. ; King, O. ; Wallenberg, J. ; Prewitt, S. ; Phillips, J. / Peak cerebrospinal fluid platinum levels in a patient with ependymoma : Evaluation of two different methods of cisplatin administration. In: Cancer Treatment Reports. 1986 ; Vol. 70, No. 12. pp. 1437-1438.
@article{9f58a4c657ad496e90550b3990e8e653,
title = "Peak cerebrospinal fluid platinum levels in a patient with ependymoma: Evaluation of two different methods of cisplatin administration",
abstract = "Peak CSF and serum platinum levels were examined in a patient with ependymoma after each of four consecutive cisplatin doses of 100 mg/m2 administered by either 30-minute or 3-hour infusion. Both infusion lengths produced similar peak CSF platinum levels within 2 hours after the completion. Ultrafiltrate serum platinum levels correlated with the CSF platinum levels, whereas total plasma platinum did not. No differences in clinical toxicity or response were seen between the two methods of administration. Based on these preliminary results, similar peak CSF platinum concentrations are achieved by 30-minute or 3-hour infusions, and ultrafiltrate serum platinum concentrations can be used to predict these levels.",
author = "M. DeGregorio and B. Wilbur and O. King and J. Wallenberg and S. Prewitt and J. Phillips",
year = "1986",
language = "English (US)",
volume = "70",
pages = "1437--1438",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Peak cerebrospinal fluid platinum levels in a patient with ependymoma

T2 - Evaluation of two different methods of cisplatin administration

AU - DeGregorio, M.

AU - Wilbur, B.

AU - King, O.

AU - Wallenberg, J.

AU - Prewitt, S.

AU - Phillips, J.

PY - 1986

Y1 - 1986

N2 - Peak CSF and serum platinum levels were examined in a patient with ependymoma after each of four consecutive cisplatin doses of 100 mg/m2 administered by either 30-minute or 3-hour infusion. Both infusion lengths produced similar peak CSF platinum levels within 2 hours after the completion. Ultrafiltrate serum platinum levels correlated with the CSF platinum levels, whereas total plasma platinum did not. No differences in clinical toxicity or response were seen between the two methods of administration. Based on these preliminary results, similar peak CSF platinum concentrations are achieved by 30-minute or 3-hour infusions, and ultrafiltrate serum platinum concentrations can be used to predict these levels.

AB - Peak CSF and serum platinum levels were examined in a patient with ependymoma after each of four consecutive cisplatin doses of 100 mg/m2 administered by either 30-minute or 3-hour infusion. Both infusion lengths produced similar peak CSF platinum levels within 2 hours after the completion. Ultrafiltrate serum platinum levels correlated with the CSF platinum levels, whereas total plasma platinum did not. No differences in clinical toxicity or response were seen between the two methods of administration. Based on these preliminary results, similar peak CSF platinum concentrations are achieved by 30-minute or 3-hour infusions, and ultrafiltrate serum platinum concentrations can be used to predict these levels.

UR - http://www.scopus.com/inward/record.url?scp=0022869676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022869676&partnerID=8YFLogxK

M3 - Article

VL - 70

SP - 1437

EP - 1438

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 12

ER -